Literature DB >> 19446733

Phosphoproteomic analysis of chemokine signaling networks.

Morgan O'Hayre1, Catherina L Salanga, Pieter C Dorrestein, Tracy M Handel.   

Abstract

Chemokines induce a number of intracellular signaling pathways by activating second messengers (e.g. calcium) and phosphorylation cascades in order to mediate a myriad of functions including cell migration, survival and proliferation. Although there is some degree of overlap in chemokine receptor-mediated pathway activation, different chemokines will often elicit distinct signaling events. Factors such as cell type, receptor expression levels, G protein availability, and disease state will also influence the signaling response from chemokine-induced receptor activation. Improvements in mass spectrometry, enrichment strategies, and database search programs for identifying phosphopeptides have made phosphoproteomics an accessible biological tool for studying chemokine-induced phosphorylation cascades. Although signaling pathways involved in chemokine-mediated migration have been fairly well characterized, less is known regarding other signaling cascades elicited by chemokines (e.g. to induce proliferation) or the potential for distinct pathway activation in a disease state such as cancer. CXCL12(SDF-1)/CXCR4 signaling has been shown to play an important role in the survival of chronic lymphocytic leukemia (CLL) cells, and thus provides a good system for exploring chemokine signaling, particularly in the interest of survival pathway activation. In this chapter, we describe the use of immobilized metal affinity chromatography (IMAC) phosphopeptide enrichment followed by reversed-phase liquid chromatography and tandem mass spectrometry (LC-MS/MS) analysis for exploring CXCL12-mediated signaling in human CLL patient cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446733     DOI: 10.1016/S0076-6879(09)05216-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  6 in total

1.  Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.

Authors:  Davorka Messmer; Jessie-F Fecteau; Morgan O'Hayre; Ila S Bharati; Tracy M Handel; Thomas J Kipps
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

2.  Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.

Authors:  Morgan O'Hayre; Catherina L Salanga; Thomas J Kipps; Davorka Messmer; Pieter C Dorrestein; Tracy M Handel
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

3.  The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.

Authors:  Douglas P Dyer; Catherina L Salanga; Brian F Volkman; Tetsuya Kawamura; Tracy M Handel
Journal:  Glycobiology       Date:  2015-11-17       Impact factor: 4.313

4.  A general method for site specific fluorescent labeling of recombinant chemokines.

Authors:  Tetsuya Kawamura; Bryan Stephens; Ling Qin; Xin Yin; Michael R Dores; Thomas H Smith; Neil Grimsey; Ruben Abagyan; Joann Trejo; Irina Kufareva; Mark M Fuster; Catherina L Salanga; Tracy M Handel
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

5.  Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization.

Authors:  Douglas P Dyer; Elisa Migliorini; Catherina L Salanga; Dhruv Thakar; Tracy M Handel; Ralf P Richter
Journal:  Open Biol       Date:  2017-01       Impact factor: 6.411

6.  The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.

Authors:  Douglas P Dyer; Catherina L Salanga; Scott C Johns; Elena Valdambrini; Mark M Fuster; Caroline M Milner; Anthony J Day; Tracy M Handel
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.